Abstract:Abstract Targeted protein degradation can be induced with monovalent small molecules, termed molecular glues, that modify the substrate-binding interface of E3 ligases and reroute them to novel targets. Despite there being over 600 E3 ligases encoded in the human genome, most glues have focused on only a few. Expanding to additional ligases and targets is challenging due to the low probability of successful 'glueing.' Many have suggested that a weak basal interaction between a ligase and neo-substrate is an important prerequisite for the function of a molecular glue, but such weak interactions are challenging to discover. To address this need, we have harnessed AlphaSeq, a synthetic biology platform that measures protein-protein interactions at scale and with high sensitivity, to identify and characterize novel E3-target pairs. Our approach is twofold. First, we test for novel weak interactions (~100nM to 10uM) between a panel of E3 ligases and a library of disease relevant target proteins. Second, starting from a weakly interacting protein pair, we build mutational libraries of both proteins and measure their binding strengths. Mutations that strengthen binding serve to validate the weak interaction, provide structural insights into the nature of binding, and help to inform subsequent small molecule discovery. Here, we present our approach to discover and evaluate glueable ligase-target pairs using AlphaSeq, validation through proof-of-concept experiments involving a known interaction agonized by small molecules, and examples of novel glueable ligase-target pairs that we have recently discovered. Citation Format: Arpita Sen, Phil Burke, Ruchi Bansal, Dasha Krayushkina, David Noble, Kerry McGowan, Natasha Seelam Murakowska, Paxton Reed, Juliana Barrett, Randolph Lopez. A high-throughput approach to discover and characterize glueable ligase-target pairs [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 4500.

Discovery of molecular glues that bind FKBP12 and novel targets using DNA-barcoded libraries

Discovery of fully synthetic FKBP12-mTOR molecular glues

Molecular Glue Discovery: Current and Future Approaches.

Design and structure-based study of new potential FKBP12 inhibitors.

Binding Modes and Conformational Changes of FK506-binding Protein 51 Induced by Inhibitor Bindings: Insight into Molecular Mechanisms Based on Multiple Simulation Technologies

Protein-templated Ligand Discovery Via the Selection of DNA-encoded Dynamic Libraries

Quantifying Cooperativity Through Binding Free Energies in Molecular Glue Degraders

Discovery of BAY 2666605, a Molecular Glue for PDE3A and SLFN12

FK506-binding protein 12 ligands: a patent review.

A platform for the rapid synthesis of molecular glues (Rapid-Glue) under miniaturized conditions for direct biological screening

FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/neuroprotective properties of substituted 5,5-dimethyl-2-(4-thiazolidine)carboxylates.

Abstract 4500: A high-throughput approach to discover and characterize glueable ligase-target pairs

Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery

Identification of isoform/domain-selective fragments from the selection of DNA-encoded dynamic library

Dual-site molecular glues for enhancing protein-protein interactions of the CDK12-DDB1 complex

Identification and Evaluation of Reversible Covalent Binders to Cys55 of Bfl-1 from a DNA-Encoded Chemical Library Screen

Unveiling the hidden interactome of CRBN molecular glues with chemoproteomics

Abstract 3091: Discovery of highly selective ligands with unique binding modes for challenging oncology targets using DNA-encoded chemical libraries

Screening Ultra-Large Encoded Compound Libraries Leads to Novel Protein-Ligand Interactions and High Selectivity

Discovery of pentapeptide-inhibitor hits targeting FKBP51 by combining computational modeling and X-ray crystallography

Cover Picture: Selection of DNA‐Encoded Small Molecule Libraries Against Unmodified and Non‐Immobilized Protein Targets (angew. Chem. Int. Ed. 38/2014)